Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer.

Blood - 15 Jun 2006

Slager Elisabeth H, Honders M Willy, van der Meijden Edith D, van Luxemburg-Heijs Simone A P, Kloosterboer Freke M, Kester Michel G D, Jedema Inge, Marijt W A Erik, Schaafsma M Ron, Willemze Roel, Falkenburg J H Frederik

Abstract excerpt

Characterization of the antigens recognized by tumor-reactive T cells isolated from patients successfully treated with allogeneic HLA-matched hematopoietic stem cell transplantation (SCT) can lead to the identification of clinically relevant target molecules. We isolated tumor-reactive cytotoxic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8-Positive T-Lymphocytes
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Hematopoietic Stem Cells

Share to Immunotherapy

Share to Multiple Myeloma

Share to Thymidine Phosphorylase

Share to Transplantation, Homologous

Source

Identifiers

PMID: 16497972
DOI: 10.1182/blood-2005-09-3883

Genes

SCT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16497972-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer.PMID 16497972Read ↗

C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.Semantic proximity Read ↗

A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.Semantic proximity Read ↗

CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.Semantic proximity Read ↗

Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens.Semantic proximity Read ↗

Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneSemantic proximity Read ↗

Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.Semantic proximity Read ↗

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production.Semantic proximity Read ↗

One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.Semantic proximity Read ↗

Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interest.Semantic proximity Read ↗

Isolation and Characterization of an HLA-DPB1*04:01-restricted MAGE-A3 T-Cell Receptor for Cancer ImmunotherapySemantic proximity Read ↗

Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.